May 20, 2011

LINKEDIN (LNKD): LOW RISK WAYS TO MAKE MONEY

LinkedIn (LNKD) frenzy continues.

Fundamentals do not justify buying LinkedIn at this level. LinkedIn is no Google (GOOG).

Options will start trading Thursday and stock should become available for shorting after that. An analysis of the historical data of similar situations shows that shorting this stock in the near term will be a disaster.

There are low risk ways to make money from LinkedIn. Here are the excerpts from my article on Seeking Alpha:

LinkedIn: Overvalued, But a Dangerous Short

LinkedIn (LNKD) went public Thursday, setting a frenzy on Wall Street. It was not that long ago that LinkedIn shares were expected to be priced in the mid 30’s.

… Please click here or the title below to read more.

May 20, 2011

TAKING PARTIAL PROFITS ON LIMITED BRANDS (LTD)

We are taking partial profits on LTD right here at $39.22. We will leave the rest to hit our target zone.… Please click here or the title below to read more.

May 20, 2011

ACORDA THERAPEUTICS (ACOR) UP MOVE IS AN OPPORTUNITY

Acorda Therapeutics (ACOR) is up due to the positive opinion on Marketing Authorization Application for its MS drug Ampyra in Europe. This approval for Acorda Therapeutics was expected. The big move in Acorda is unwarranted.

We are short selling in the strength now with an average price $32.98 and will add if the stock goes higher.

As a full disclosure, this alert was earlier published in ZYX Short Sell Change Alert — Real Time Feed. For stops and targets please see ZYX Short Sell Change Alert.

… Please click here or the title below to read more.

May 20, 2011